Streamline Health Solutions (NASDAQ:STRM) Coverage Initiated by Analysts at StockNews.com

StockNews.com assumed coverage on shares of Streamline Health Solutions (NASDAQ:STRM) in a research report sent to investors on Monday morning. The brokerage issued a sell rating on the stock.

Separately, Craig Hallum raised shares of Streamline Health Solutions to a “strong-buy” rating in a research report on Thursday, September 5th.

Streamline Health Solutions Price Performance

Shares of NASDAQ:STRM opened at $2.92 on Monday. The firm has a market capitalization of $12.33 million, a PE ratio of -0.59 and a beta of 1.64. Streamline Health Solutions has a 1-year low of $1.85 and a 1-year high of $9.75. The company has a current ratio of 0.61, a quick ratio of 0.61 and a debt-to-equity ratio of 0.66. The business’s 50 day moving average is $2.62 and its 200-day moving average is $5.41.

Streamline Health Solutions (NASDAQ:STRM) last issued its earnings results on Wednesday, September 11th. The company reported ($0.75) EPS for the quarter, missing the consensus estimate of ($0.60) by ($0.15). The firm had revenue of $4.48 million during the quarter. Streamline Health Solutions had a negative net margin of 92.72% and a negative return on equity of 44.85%.

Streamline Health Solutions Company Profile

Streamline Health Solutions, Inc offers health information technology solutions and associated services for hospitals and health systems in the United States and Canada. The company offers RevID, an automated revenue reconciliation software; eValuator, a coding analysis platform; data comparison engine; coding and clinical documentation improvement (CDI) solutions, including CDI, abstracting, and physician query; and financial management solutions, such as accounts receivable management, denials management, claims processing, spend management, and audit management.